CHAP Child

Enrolling By Invitation
99 years or below
All
Phase N/A
1 Location

Brief description of study

CHAP Child is a follow-up study to the CHAP Randomized Trial. The study will follow up the children born to CHAP Trial participants with a target follow up age of 7 years and older. This protocol seeks to define the long-term safety of routine prenatal pharmacologic treatment of mild CHTN on childhood ND and growth and to determine whether preeclampsia superimposed on mild CHTN is associated with childhood outcomes including ND, growth and other cardio-metabolic outcomes.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 17 Jun 2025. Study ID: 24-1102
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research